ALPROSTADIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Alprostadil, and when can generic versions of Alprostadil launch?
Alprostadil is a drug marketed by Hikma and Meitheal and is included in two NDAs.
The generic ingredient in ALPROSTADIL is alprostadil. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the alprostadil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Alprostadil
A generic version of ALPROSTADIL was approved as alprostadil by HIKMA on January 20th, 1998.
Summary for ALPROSTADIL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Clinical Trials: | 38 |
Patent Applications: | 4,457 |
DailyMed Link: | ALPROSTADIL at DailyMed |
Recent Clinical Trials for ALPROSTADIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kafrelsheikh University | N/A |
First Hospital of Jilin University | Phase 4 |
The First Hospital of Jilin University | Phase 4 |
Medical Subject Heading (MeSH) Categories for ALPROSTADIL
Anatomical Therapeutic Chemical (ATC) Classes for ALPROSTADIL
US Patents and Regulatory Information for ALPROSTADIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | ALPROSTADIL | alprostadil | INJECTABLE;INJECTION | 074815-001 | Jan 20, 1998 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Meitheal | ALPROSTADIL | alprostadil | INJECTABLE;INJECTION | 075196-001 | Apr 30, 1999 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |